US 2016/0250184 A1Published application

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

AssigneeMerck Sharp & Dohme Corp.

InventorsSONGNIAN LIN, Libo Xu, Emma R. Parmee, Xibin Liao

Life of this patent

Estimating the term…

Abstract

Glucagon receptor antagonist compounds are disclosed which are of long duration of action. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Claims12

Dependent claims

A compound which is:

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 15/030,779Filed 30 Oct 2014
Priority: 4 Nov 2013
Published: 1 Sep 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 31/404
Condensed with carbocyclic rings, e.g. carbazole: indoles, e.g. pindolol
A61K 31/397
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having four-membered rings, e.g. azetidine
A61K 31/4035
Condensed with carbocyclic rings, e.g. carbazole: isoindoles, e.g. phthalimide
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…

Family

Application61/899,374Us provisional application · filed 4 Nov 2013
US 9,649,294 B2Related patent
US 2016/0250184 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results